indole-3-carbaldehyde has been researched along with Cardiometabolic Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barola, C; Borghi, M; Costantini, C; Galarini, R; Giovagnoli, S; Moretti, S; Mosci, P; Pariano, M; Puccetti, M; Ricci, M | 1 |
1 other study(ies) available for indole-3-carbaldehyde and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Enteric formulated indole-3-carboxaldehyde targets the aryl hydrocarbon receptor for protection in a murine model of metabolic syndrome.
Topics: Animals; Disease Models, Animal; Indoles; Metabolic Syndrome; Mice; Receptors, Aryl Hydrocarbon | 2021 |